Stem-cell technique may spare embryo

US scientists have devised a technique for obtaining embryonic stem cells without harming or destroying an embryo. Successful in mice, the technique could circumvent moral objections to stem-cell research if it works similarly for human embryos.

- read this report from Science Daily for more

PLUS: Scottish biotech Stem Cell Sciences won extensions to its US patent rights and plans to launch a US business development subsidiary next year. Story

Suggested Articles

AbbVie snagged the option to license Harpoon’s anti-BCMA multiple myeloma candidate and the duo added up to six new targets to their discovery deal.

In this week's EuroBiotech Report, Bayer's heart failure drug clears phase 3 test, ABPI calls for more U.K. investment and GHO raises €975 million. 

In our EuroBiotech roundup this week, Azeria raises £32 million, Zealand delays phase 3 readout and Galapagos eyes early 2021 IPF futility analysis.